Fathomx

FathomX is a MedTech AI spin-off from the National University of Singapore and National University Health System that aims to deploy clinician friendly solutions to enhancing the existing workflow. Our first project targets public health and aims to enhance breast cancer screening with AI by significantly reducing false positive rates by 80% and enhancing the clinical workflow by cutting down the clinician number by 50%. These are findings that have been published in the prestigious JAMA Open Network and Workshop. The company works closely with global solutions provider HP Enterprise to develop a range of technologies in the field of medical imaging and has integrated our AI engines into a technical infrastructure that is scalable, customisable and already tested out in various hospitals and clinics.